Search PubMed⌕ Search

Biomedical subjects

P Noel

Publications and source records attributed to P Noel.

At least 37 records · Page 2Linked to original sources
PubMed1991

Differential expression of isopeptide bonds N epsilon (gamma-glutamyl) lysine in benign and malignant human breast lesions: an immunohistochemical study.

N epsilon (gamma-glutamyl) lysine isopeptide bonds were detected in situ in histological sections from benign and malignant human breast tissue using the monoclonal antibody (MAb) 81D1c2. On cryostat sections of fresh-frozen mammary tissue post-fixed in acetone, or on paraffin sections also from mammary tissue fixed in Bouin's solution, the MAb reacted preferentially with glandular epithelial cells and staining was restricted to the nuclei. In 41 out of 44 benign lesions examined, staining was strong or moderate, while in 25 out of 33 malignant lesions no staining was observed. In the 8 remaining lesions of this group, staining was positive but weak. The difference in reactivity of this MAb with the 2 types of lesions is highly significant (p less than 0.0005) according to the chi 2 test.

Adult↗
PubMed1991

A Canadian model for developing mental health services in rural communities through linkages with urban centers.

The development of mental health care services in rural areas has been a constant challenge in most countries of significant geographical size. By use of a case study from Canada, the development of a relationship between rural and urban mental health services was described. Issues including referral patterns, service accessibility, professional recruitment and the development of service in rural regions were studied. It is advanced that mental health administrators, policy-makers, clinical service coordinators and educators will find that this approach to the development of mental health services in rural areas has some utility in Canada and in other countries.

Canada↗
PubMed1991

Atrial fibrillation as a risk factor for deep venous thrombosis and pulmonary emboli in stroke patients.

In 539 consecutive stroke patients admitted to a rehabilitation department, we studied the possible role of atrial fibrillation as a risk factor for deep venous thrombosis and pulmonary embolism by analyzing a series of relevant clinical data in patients with and without atrial fibrillation and in patients with and without venous thromboembolic complications. Deep venous thrombosis as well as advanced age and cardiac disease were significantly (p less than 0.001) more frequent in patients with atrial fibrillation. However, in a model of simultaneous logistic regression carried out on the presence of absence of venous thromboembolic complications, atrial fibrillation was the only significant risk factor. In view of the morbidity and mortality linked to deep venous thrombosis, our findings argue for preventive anticoagulation therapy in stroke patients suffering from atrial fibrillation and merit further study.

Aged↗
PubMed1991

[Prognostic value of lympho node micrometastases detected by immunohistochemistry. Study of 168 cases of breast cancer with a 10-year follow-up].

The authors reported a retrospective pathological study of 168 patients classified PT2N- treated by Patey mastectomy completed by axillary and internal mammary lymph node removal. The size of micrometastases ranged from 0.012 to 0.87 millimeters. All 2800 lymph nodes were examined, using successively HPS and IHC procedures. Detection of micrometastases has been improved by immunohistochemical staining on paraffin embedded sections using anticytokeratin MAb clone antiKL1. The 168 patients were divided into two groups. The first one included 31 patients IHC+ out of 168 (18.5%); there were 47 micrometastatic nodes with negatives nodes out of 2800 (1,67%). The second group included 137 patients (81.5%) out of 168 with negative nodes. If we consider the PT2N-clinical status, it appears a percentage of 16 to 20% of patients developing recurrence within ten years after surgical treatment. There was no significant difference concerning the disease--free survival at ten years. Variability in metastatic node involvement spread led us to distinguish 3 subgroups of uneven prognostic value. The relative risk of relapse ranged from 1 (ICH + 1) to 1.94 (ICH + 2 and 3) merged. Do PT2N- group with recurrence and ICH + group concern the same patients? We cannot statistically prove that micrometastatic nodes are a bad prognostic factor by further studies which are required.

Breast Neoplasms↗
PubMed1991

[Treatment of perforated peptic ulcer using the round ligament under celioscopy].

We propose an original technique of treatment of perforated peptic ulcer with celioscopic monitoring which has principles and indications similar to those of simple surgical suture via laparotomy. The procedure consists in obliterating the ulcerous perforation with the round ligament (RL) that has previously been predicled from its insertion on the liver, under celioscopy. The umbilical end of the RL is then caught with a Dormia probe inserted through the perforation with a fibrogastroscope. By pulling the probe, the RL is then inserted into the perforation and obturates it. Peritoneal washing and transcutaneous infrahepatic drainage complete the procedure. This was proposed to 9 patients (8 M, 1 F) with a mean age of 41 years (24-59) having ulcers perforated for less than 6 hours. The obliteration of the perforation using the RL was performed easily in 7 cases. In 3 cases, the procedure could not be carried out, either because the diameter of the perforation exceeded 1.5 cm (n = 2) or because of purulent peritonitis (n = 1). No postoperative complications occurred. The endoscopic control showed healed ulcers in all cases after 5 weeks of treatment with anti-H2 drugs. These still preliminary results suggest that the celioendoscopic treatment of perforated peptic ulcers might be proposed whenever vagotomy does not seem to be absolutely necessary, especially in cases of acute ulcer occurring in younger subjects. In comparison with laparotomy, this procedure prevents parietal sequellae and improves the postoperative comfort. This procedure might also be proposed as an alternative to Taylor's procedure, thus avoiding the diagnostic errors and delays in surgery that are inherent in this therapeutic method.

Adult↗
PubMed1990

Pentoxifylline inhibits lipopolysaccharide-induced serum tumor necrosis factor and mortality.

Tumor necrosis factor, a mononuclear phagocyte-derived peptide produced in response to lipopolysaccharide, has been shown to mediate certain aspects of septic shock and multiple organ failure resulting from gram-negative septicemia. In the present investigation, pretreatment of animals with pentoxifylline inhibited lipopolysaccharide-induced serum tumor necrosis factor in a dose-dependent fashion. Pentoxifylline prevented the sequestration of neutrophils seen in animals given intravenous lipopolysaccharide. Furthermore, pentoxifylline protected animals from the lethal effects of an intravenous challenge with lipopolysaccharide. These data indicate that pentoxifylline inhibits lipopolysaccharide-induced tumor necrosis factor and may be an effective agent in mitigating the lethal consequences of sepsis and other disease processes mediated by this cytokine.

Animals↗
PubMed1990

Cerebral palsy: initial experience with Tc-99m HMPAO SPECT of the brain.

The outlook for children with cerebral palsy is determined by the severity of motor problems and the presence of associated disabilities, in which early detection remains a medical challenge. The authors studied 13 children (aged 13 months to 12 years) with cerebral palsy by means of single photon emission computed tomography (SPECT) of the brain with technetium-99m hexamethylpropyleneamineoxime (HMPAO). In all children with hemiplegia, SPECT demonstrated hypoperfusion in the hemisphere contralateral to the motor deficit. SPECT demonstrated normal findings in patients with mild diplegia; bilateral hypoperfusion in the superior motor cortex in patients with moderate di- or tetraplegia; and bilateral reduction of perfusion in the superior motor, inferior motor, prefrontal, and parietal cortices in patients with severe di- or tetraplegia. Results suggest that Tc-99m HMPAO SPECT of the brain is a valuable complementary tool for thorough neurologic assessment in cerebral palsy.

Brain↗
PubMed1989

Phase I clinical trial with carbetimer.

Carbetimer, a low molecular weight polymer derived from ethylene and maleic anhydride, belongs to a class of chemical compounds different from previously available anticancer agents. It has shown moderate antitumor activity against the Madison 109, Lewis lung, colon 26 and M5076 ovarian carcinomas. In the human tumor stem cell assay, antitumor activity was seen against carcinomas of the breast, ovary, lung, colon and kidney. A total of 26 patients with solid tumors were entered into this trial; carbetimer was given on 5 consecutive days as a 1-2-h intravenous infusion. The dose was escalated from 1.08 to 11 g/m2/day. The drug did not induce the usual side-effects of chemotherapy: leukopenia, thrombocytopenia, alopecia and mucositis were minimal or totally absent. Gastrointestinal toxicity was limited to mild to moderate nausea and vomiting; these were observed at all dose levels and required antimetics in only two patients. The major side-effects of carbetimer consisted of hypercalcemia and neurotoxicity. Hypercalcemia was dose- and treatment duration-dependent. The precise mechanism of hypercalcemia is presently under investigation, but remains unclear. Neurotoxicity was observed only after prolonged therapy; two patients, who received cumulative doses higher than 250 g/m2, developed a peripheral neuropathy with paresthesia, decrease in sensory perception and motor weakness. One patient recovered completely; the other patient improved slightly before developing fatal brain metastases. Two patients with malignant melanoma exhibited major antitumor response; both were previously treated; after excellent partial responses to carbetimer, both were operated on and one is presently disease-free 2 1/2 years after completion of therapy with carbetimer. In conclusion, carbetimer is a new compound with an unusual pattern of side-effects and interesting antitumor activity against malignant melanoma. Its antitumor activity is presently being investigated in phase II trials.

Adult↗
PubMed1989

[Detection of micrometastases in excised regional lymph nodes in cancer of the breast. Systematic use of KL1 anticytokeratin monoclonal antibodies in a prospective series of 120 T2 N- patients].

A series of 120 patients (T2, No, N1a according to UICC classification) with mammary cancer treated by mastectomy and regional lymph node dissection, classified T2N-after Hemalun-Phloxine Safran (HPS) standard sections, have a positive reaction with immunohistochemical staining (IHM) using monoclonal antibodies (anti KL1) so that IHM improve the detection of lymph node metastases. 13 patients out of 120 presumed N-after HPS technic became positive with IHM staining. We examined 2108 lymph nodes and noticed 19 N+, the size of which was less than 2 millimeters. Microscopically, three main aspects are follows. Micrometastases made of clusters of malignant cells; micrometastases with single cells in file, and a composite aspect from both previous ones. Metastatic cells detected by anti KL1 have an excellent contrast due to clear nucleus surrounded by a large rim of dark cytoplasm. Although T2N-has a better prognosis than T2N+, 10 to 20% of patients relapsed within ten years after surgical treatment. It is important to determine whether the detection of occult micrometastases permits to predict recurrence. Is it a relevant correlation or not? if such a connection does'not exist, micrometastasis detection became irrelevant; on the contrary, if it exists, the therapists can launch on adequate adjuvant treatment - useful only - for patients with high risk of relapse.

Antibodies, Monoclonal↗
PubMed1987

Plasma cell leukemia: an evaluation of response to therapy.

Forty-three patients with plasma cell leukemia were seen at the Mayo Clinic. Twenty-five (58 percent) had primary plasma cell leukemia (diagnosis first made in the leukemic phase) and 18 (42 percent) had secondary plasma cell leukemia (leukemic transformation of a previously diagnosed multiple myeloma). Patients with secondary plasma cell leukemia were older, had a greater incidence of lytic bone lesions, had a lower platelet count, and had a larger M-protein in the serum than did patients with primary plasma cell leukemia. The median survival was 6.8 months for patients with primary plasma cell leukemia and 1.3 months for patients with secondary plasma cell leukemia. In patients with primary plasma cell leukemia, multiple alkylating agents produced a higher response rate than did melphalan, but the median time from treatment to progression or death was not significantly improved with such therapy. Review of the literature also suggests that the response rate is higher with combination chemotherapy than with single alkylating agents. Patients with secondary plasma cell leukemia usually show resistance to any type of chemotherapy and have a short survival.

Adult↗
PubMed1987

Unusual cause of cerebellar abscess: occipital dermal sinus and dermoid cyst.

Cerebellar abscess induced by a contiguous dermal sinus is a rare event. In a large series of acute posterior fossa abscedation, otogenic suppuration is the cause in 93% of the cases, while hematogenous infection is infrequent, probably because of the relatively weak bloodflow in this part of the central nervous system. The authors present an occipital dermal sinus and dermoid cyst revealed by a cerebellar abscess. The literature is reviewed briefly, treatment and prophylactic measures are discussed.

Brain Abscess↗
PubMed1987

Monoclonal proteins in chronic lymphocytic leukemia.

One hundred patients with chronic lymphocytic leukemia and a monoclonal protein in serum or urine were recognized during the period January 1971 to July 1984. IgG monoclonal proteins predominated, with the following distribution: IgG kappa 36% (0.36), IgG lambda 15% (0.15), IgM kappa 27% (0.27), IgM lambda 11% (0.11), IgA lambda 1% (0.01), and free monoclonal light chains in 10% (0.10) (kappa in 8% [0.08] and lambda in 2% [0.02]). The median concentration of M-protein was 1.0 g/dL (10 g/L) or less. The median survival (Kaplan-Meier) for the 100 patients after recognition of an M-protein was six years. The median survival was longer for patients with an IgG monoclonal protein (7.2 years) than for patients with an IgM monoclonal protein (5.2 years), although the difference was not significant. The authors found no important differences in patients with chronic lymphocytic leukemia, whether they had an IgG or an IgM monoclonal protein or a free monoclonal light chain.

Adult↗
PubMed1986

Ultrasound, computed tomography and magnetic resonance of a neonatal ganglioglioma of the brain.

Ganglioglioma is an uncommon nerves-cell tumour (0.4% of all brain tumours). In 800 brain tumours in children, Garrido et al. (Toronto) found 14 gangliogliomas (1.7%). To our knowledge, ganglioglioma has not been reported in children under 2 1/2 years of age. We have incidentally discovered a ganglioglioma in a 3-day-old girl. Appearance on US, CT and MR are described and discussed.

Brain Neoplasms↗
PubMed1986

Bilateral primary traumatic oculomotor nerve palsy.

Two cases with bilateral traumatic oculomotor palsy are presented. The clinical signs, diagnosis criteria, and mechanisms of injury are discussed with a special emphasis on the absence of early reliable prognosis factors. The possibility of recovery depends on the anatomic lesion and not on the ophthalmologic findings in the acute phase.

Child↗
PubMed1985

Prognostic value of the topographic grid method in women with T2 N- breast cancer. Statistical results from a series of 203 patients.

In 1977, the authors described the grid method, a topographic technique for mapping the microscopic spread of breast cancer. The current report describes the relapse-free survival of a series of 203 patients with T2 N- mammary cancer (T2 N0 N1 ab N-) who were treated by mastectomy and regional lymph node dissection and have been followed since 1974. A good prognosis did not prevent relapse in 15% to 20% of patients within the first 5 years. To determine whether the grid method can identify patients at high risk within this group, disease-free survival and survival were compared in two subsets, a "limited" group (L) and a "diffuse" group (D). The difference between the two groups was statistically significant for both parameters (88%) versus 77% and 93% versus 85% after 5 years) (P less than 0.01 and P less than 0.02). Other prognostic measures were uniformative. Thus, the grid method has a good prognostic score when compared with the factors usually measured--menopausal status, estrogen receptors, histologic type--and could be used to select appropriate adjuvant therapy in breast cancer.

Breast Neoplasms↗
PubMed1985

Peroneal motor nerve conduction velocity in diabetic children and adolescents. Relationships to metabolic control, HLA-DR antigens, retinopathy, and EEG.

To investigate incipient diabetic neuropathy, peroneal motor nerve conduction velocity (PMNCV) was measured in 61 diabetic children and adolescents whose type 1 diabetes became clinically apparent before the age of 14 years. PMNCV in diabetic patients (48.3 +/- 5.6 m/s) was significantly lower than in controls (56.5 +/- 5.5 m/s), 23 diabetics (36%) having a value more than 2 SD below the mean for normals. There was a highly significant negative correlation between PMNCV and HbA1 levels concomitant with PMNCV measurement or mean annual HbA1 concentrations preceding PMNCV. The relationship between PMNCV and the clinical score of diabetic control since the onset of the disease was also significant. Age, duration of diabetes and HLR-DR antigens were unrelated to PMNCV. EEG abnormalities and retinopathy, whose pathogenesis is different, were not necessarily associated with subclinical neuropathy. Being easy and sensitive, PMNCV determination provides the paediatric diabetologist and the patient himself with an important motivation to improve diabetic control.

Adolescent↗
PubMed1985

Chromosome abnormalities in malignant hematologic disorders.

Certain chromosome abnormalities have been detected in routine cytogenetic studies of patients with hematologic disorders. This article is a cytogenetic and clinical review of 28 structural and 15 numeric chromosome abnormalities. As a group, the structural abnormalities involved 40 different chromosome breakpoints and included 13 types of translocations, 8 deletions, 3 isochromosomes, 3 inversions, and 1 duplication. The numeric abnormalities included 4 types of monosomy, 10 trisomies, and a near-haploid category. We determined the relative frequency for each of these anomalies in our practice by reviewing the results of 1,228 consecutive specimens studied between 1979 and 1984 in which a chromosomally abnormal clone was found; 61% of these specimens had one or more of the selected anomalies. The three most common translocations were 9;22 translocations (378 specimens), 8;21 translocations (15 specimens), and unbalanced abnormalities derived from 1;7 translocations (13 specimens). The two most common deletions were those involving the long arm of chromosomes 5 (101 specimens) and 20 (65 specimens). The most common isochromosome was i(17q) (33 specimens). The two most common types of monosomy were loss of a Y chromosome (118 specimens) and monosomy 7 (97 specimens). The three most common trisomies were + 8 (161 specimens), +21 (53 specimens), and +19 (31 specimens). Each of the 43 anomalies was observed in patients with different types of hematologic disorders, but in most cases one kind of neoplasm usually predominated.

Chromosome Aberrations↗